Trials / Unknown
UnknownNCT03635398
Intranasal Midazolam for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety Using sipNose Device - a Randomized Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
A Three-arm, Randomized Controlled Trial for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety: Intranasal Midazolam by SipNose versus MAD Versus oral administration
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sipnose device | SipNose's intranasal drug delivery platform uses an innovative mechanism that is suposed to improves efficacy, patient compliance and safety |
| DEVICE | MAD (Mucosal Atomization Device) | MAD (Mucosal Atomization Device) |
| DRUG | midazolam | oral administration of midazolam |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2018-08-17
- Last updated
- 2018-08-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03635398. Inclusion in this directory is not an endorsement.